LINDA SILVA: Open Payments
NPI 1992860100 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 10 payments from 8 companies in 2025. Trend: 2023 $775 · 2024 $994 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $57 |
| GENZYME CORPORATION | 1 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Lilly USA, LLC | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| UCB, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $14 |
Products named: DUPIXENT, SKYRIZI, EBGLYSS, Zoryve, Otezla, Bimzelx, OPZELURA.
Industry payments across AZ — which companies pay providers there.
